Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Some people may experience decreased appetite, which contributes to weight loss
We prescribe four FDA-approved GLP-1 medications: Mounjaro (tirzepatide), Zepbound (tirzepatide), Wegovy (semaglutide), and Ozempic (semaglutide)
Many compounded semaglutide formulations must remain refrigerated at all times and should not be kept at room temperature unless your prescription label indicates otherwise
Semaglutide Since its launch in 2017, semaglutide (brand name Ozempic & Rybelsus for type 2 diabetes launched in 2019, and Wegovy for weight-loss launched in 2021) has become the leading GLP-1 in diabetes and the companys most significant growth driver
